Numerate
1501 Mariposa Street
Suite 426
San Francisco
California
94107
United States
Website: http://www.numerate.com/
Email: info@numerate.com
22 articles about Numerate
-
Numerate Receives $2 Million SBIR Phase II Award to Continue Research Using Its AI-Driven Discovery Platform to Identify New Antiarrhythmic Drug
8/7/2019
Numerate and the UCLA Cardiovascular Research Laboratory to advance collaboration to identify superior therapy for treatment and prevention of ventricular tachycardias and fibrillation
-
Numerate and Lundbeck Partner to Apply AI Drug Discovery to Unlock Challenges of Neuroscience Research
1/7/2019
Collaboration sets out to identify potential treatment candidates for disorders of the central nervous system including depression, psychosis, seizure and neurodegenerative disorders.
-
National Institutes of Health Awards Grant to Numerate to Develop Compounds that Enhance Bone Integration of Orthopedic Devices
11/15/2017
Numerate will collaborate with researchers at Mayo Clinic on the discovery of compounds for surface coating of endoprosthetic device.
-
Numerate Enhances Platform Through Acquisition of DeepCrystal Technology
10/20/2017
Numerate, the world’s leading computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery has acquired DeepCrystal’s small molecule design platform.
-
Numerate And Takeda Enter Agreement To Generate Novel Clinical Candidates Using AI-Driven Drug Discovery
6/12/2017
-
Backed By New Investors Such As Lilly Ventures, Bay Area's Numerate Secures $8 Million
6/24/2014
-
Numerate’s Drug Design Platform Scales to 10,000+ Cores Using Spot Instances
7/10/2012
-
Numerate Announces Integration With Google Inc. Compute Engine
6/29/2012
-
Numerate Forms Drug Discovery Collaboration with Merck & Co., Inc. to Utilize Numerate’s In Silico Drug Design Technology
3/14/2012
-
Numerate and Boehringer Ingelheim (Canada) Ltd. Form Research Collaboration Based on in silico Drug Design Technology
12/6/2011
-
Numerate Appoints David Jobes, Ph.D., Senior Vice President of Business and Corporate Development
4/20/2011
-
Numerate Awarded U.S. Department of Defense Contract to Extend Drug Design Platform
9/9/2010
-
Congresswoman Speier to Join Numerate in Announcing U.S. Department of Defense Contract for Speeding Design of Biowarfare Countermeasures
9/7/2010
-
Numerate and Intellikine, Inc. Conclude Research Collaboration to Discover Selective Inhibitors Against PI3 Kinase Alpha
8/11/2010
-
Numerate's Ranking Technology for Pharmaceutical R&D Gains U.S. Patent
5/27/2010
-
Presidio Pharmaceuticals, Inc. and Numerate Conclude Research Collaboration; New Lead Compounds Targeting Hepatitis C Virus Discovered
4/23/2010
-
Numerate Closes $5.5 Million Series B Financing
3/18/2009
-
Numerate Awarded Phase 1 National Institutes of Health (NIH) Grant to Support Design of New Therapies for Celiac Disease
3/18/2009
-
Numerate Raises 5.5 Million Series B
3/16/2009
-
Numerate Completes $4 Million Financing
11/18/2008